Levetiracetam
Product Images NDC 33261-644

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 33261-644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 0 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 1)

This is a formula to calculate the total daily dose of a medication in milliliters based on the patient's weight and the daily dose given in milligrams per kilogram of body weight. The medication concentration is 100 milligrams per milliliter.*

FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 10)

This is a description of a medication called "Levetiracetam". It is manufactured by AIDAREX PHARMACEUTICALS LLC in Goa, India. The medication comes in a tablet form and each tablet contains 600mg of "Levetiracetam". The tablets are film-coated and packed in a container with 30 tablets. The NDC (National Drug Code) for this medication is 33261084630. The medication is a generic version of "Keppra". It should be taken multiple times a day at specific intervals.*

FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 11)

LevenimacETan 780MG is a film-coated medication with active ingredient 548 Levitiracetam at a strength of 750MG manufactured by Lupin Limited in Goa, India. The medication is available in the form of 60 tabs with orange oval shape. The medication is a generic form of KEPPRA and is used every few hours for treating epilepsy.*

FDA Label Image

Image 1 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 2)

This appears to be a formula for estimating renal clearance (CLer) in female patients based on age, weight, and serum creatinine levels. The formula includes an initial calculation using the equation [140-age (years)] x weight (kg) ~ (x ~ 0.85) and the patient's serum creatinine level, which is then adjusted for body surface area (BSA) using the equation CLer (mL/min) = CLer (mUmin/1.73m’)s / BSA subject (m’).*

FDA Label Image

Image 2 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 3)

FDA Label Image

Image 3 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 4)

FDA Label Image

Image 4 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 5)

The text does not provide enough information to generate a useful description. It only shows percentage values of patients and treatment groups without any context or explanation.*

FDA Label Image

Image 5 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 6)

FDA Label Image

Image 6 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 7)

This appears to be a data table representing the percentage of patients in a clinical trial, separated by different groups (Placebo and Levetiracetam). The numbers represent the proportion of patients in each group, but there is not enough context to determine what specifically they are measuring.*

FDA Label Image

Image 7 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 8)

This appears to be a chart showing the percentage of patients in a study who had certain outcomes while taking either a placebo or the drug Levetiracetam. The outcomes are not specified, but the percentages range from 0% to 100%. There are also numbers indicating the number of patients in each group (84 for the placebo and 79 for Levetiracetam).*

FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 9)

This is a medication package containing Levetiracetam 250mg tablets manufactured by Lupin Limited in Goa, India. The tablets are used to treat seizures and are a generic version of Keppra. The NDC number for the package is not clear from the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.